Home » Bausch + Lomb Achieves FDA Clearance for Crystalsert Injector
Bausch + Lomb Achieves FDA Clearance for Crystalsert Injector
The FDA issued 510(k) marketing clearance for the Bausch + Lomb Cystalsert 2.6 injector.
The first-of-its-kind FDA-cleared injector can be used across the company’s suite of intraocular lenses.
The CI-26 allows for easy wound entry and helps prevent tissue snagging via an incision as small as 2.6 mm, the company said.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May